Hypertrophic cardiomyopathy (HCM), an autosomal dominant genetic disorder, arises from gene abnormalities that encode heart sarcomere proteins. Hypertrophic cardiomyopathy (HCM) is defined by an enlarged, nondilated left ventricle, perhaps accompanied by right ventricular involvement, resulting in cardiac failure and hypertrophy without systemic or other cardiac conditions.1,2 Affecting roughly 1 in 500 individuals,3 the hypertrophied wall of HCM, characterized by disordered cardiac fibers and interstitial fibrosis, leads to diminished ventricular compliance. Modified sarcomeric proteoforms have been identified in surgical specimens from patients with hypertrophic cardiomyopathy (HCM)4, 5 (Fig. 1). The presentation of HCM exhibits considerable variability, spanning from asymptomatic instances to abrupt cardiac mortality in young adults.6, 7, 8

In the absence of valvular or systemic disease, the classical presentation of hypertrophic cardiomyopathy (HCM) is identified via cardiac ultrasound by asymmetrical septal hypertrophy, characterized by an interventricular septal (IVS) thickness of at least 15 mm and an IVS to left ventricular posterior wall thickness ratio exceeding. Alternative forms of hypertrophy may affect various regions of the myocardium. Multiple subtypes of HCM exist, including those characterized by sigmoid or reverse curvature septum, neutral, apical, or midventricular hypertrophy.10, 11 The pathophysiological outcomes include systolic and diastolic dysfunction of the left ventricle.12 This study aimed to distinguish hypertrophic cardiomyopathy from healthy controls and classify before s detailed in.13 Additional researchers analyzed US pictures utilizing a CAD application. We have studied artificial intelligence to evaluate cardiovascular ultrasound pictures comprehensively14, 15 and coronary artery disease tools for classifying infarcted myocardium versus normal tissue in cardiac ultrasound images. The maximum accuracy of 99.33% in CHF diagnosis by textural feature extraction and particle swarm optimization.16 The same group accurately identified coronary artery disease using a double-density dual-tree discrete wavelet transform (DD-DTDWT) with a success rate of 96.05%.17 Entropy characteristics enabled the identification of pulmonary hypertension, with a classification accuracy of 92%.18 Additionally, significant is the computer-aided design (CAD) tool created by the same team utilizing the local preserving class separation technique19 to identify pregestational or gestational diabetes mellitus in fetuses through four-chamber ultrasonic imaging.

Using first-order statistics to characterize HCM through texture-based analysis, an SVM classifier was provided with the GLCM, and features revealed dilated cardiomyopathy and hypertrophic cardiomyopathy (HCM) by parasternal short-axis images of the heart. The left ventricle was grouped using fuzzy c-means, and features were extracted by principal component analysis and discrete cosine transform before inputting the data into various classifiers. An overall accuracy of 92.04% was achieved utilizing backpropagation neural network (BPNN) characteristics to classify normal versus sick hearts. Darwinian particle swarm optimization (DPSO) and fuzzy c-means (FCM) clustering were employed in the study by20, 21 to segment the left ventricle in the parasternal short-axis image. We attained a 90% accuracy rate for the acquired GLCM and DCT features with a support vector machine (SVM) classifier. Significant diversity exists in the clinical presentation and prognosis of HCM, even among members of the same family. Symptoms may vary from complete absence to life-threatening conditions, with sudden cardiac death (SCD) representing one of the most severe instances. Numerous unidentified genetic and nongenetic variables contribute to inadequate penetrance and variable expressivity (Fig. 2).

A multilayer convolutional neural network (CNN) model, utilizing an apical four-chamber image to diagnose HCM, achieved a robust discriminant utility with a C statistic value of 0.93, as described in.23 Using first-order statistics to characterize HCM through texture-based analysis, an SVM classifier was provided with the GLCM and features referenced in.24 This paper aims to provide an update on recent developments in the treatment and management of HCM in pediatric patients.